[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Specialty Pharmaceuticals Market Research Report by Type (CNS, Infectious diseases, Momen’s health, Oncology, and Respiratory), by Product (Oral Pharmaceuticals, Parenteral Pharmaceuticals, and Transdermal Pharmaceuticals), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

February 2021 | 182 pages | ID: SB062347E166EN
360iResearch

US$ 3,949.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Specialty Pharmaceuticals Market is expected to grow from USD 34,090.41 Million in 2020 to USD 175,441.60 Million by the end of 2025.
2. The Global Specialty Pharmaceuticals Market is expected to grow from EUR 29,891.12 Million in 2020 to EUR 153,830.52 Million by the end of 2025.
3. The Global Specialty Pharmaceuticals Market is expected to grow from GBP 26,573.27 Million in 2020 to GBP 136,755.67 Million by the end of 2025.
4. The Global Specialty Pharmaceuticals Market is expected to grow from JPY 3,638,311.43 Million in 2020 to JPY 18,724,064.53 Million by the end of 2025.
5. The Global Specialty Pharmaceuticals Market is expected to grow from AUD 49,503.82 Million in 2020 to AUD 254,764.53 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Specialty Pharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Specialty Pharmaceuticals Market studied across CNS, Infectious diseases, Momen’s health, Oncology, and Respiratory.

Based on Product, the Specialty Pharmaceuticals Market studied across Oral Pharmaceuticals, Parenteral Pharmaceuticals, and Transdermal Pharmaceuticals.

Based on Distribution Channel, the Specialty Pharmaceuticals Market studied across Hospitals & Care Providers, Online Mode, Retail Pharmacies, and Specialty Pharmacies.

Based on Geography, the Specialty Pharmaceuticals Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Specialty Pharmaceuticals Market including Accredo Health Group, Inc., Avella Specialty Pharmacy, Inc., CIGNA Pharmacy Management, CVS Health Corporation, Diplomat Pharmacy, Inc., Endo Pharmaceuticals Inc., ENESI, Humana Pharmacy, Inc., Hyphens Pharma Pte Ltd., Kroger Specialty Pharmacy, Inc., McKesson Corporation, Midatech Pharma PLC, UnitedHealth Group Incorporated, US WorldMeds, LLC, and Walgreens Boots Alliance, Inc..

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Specialty Pharmaceuticals Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Specialty Pharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Specialty Pharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Specialty Pharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Specialty Pharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Specialty Pharmaceuticals Market?
6. What are the modes and strategic moves considered suitable for entering the Global Specialty Pharmaceuticals Market?
1. PREFACE

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Define: Research Objective
  2.1.2. Determine: Research Design
  2.1.3. Prepare: Research Instrument
  2.1.4. Collect: Data Source
  2.1.5. Analyze: Data Interpretation
  2.1.6. Formulate: Data Verification
  2.1.7. Publish: Research Report
  2.1.8. Repeat: Report Update
2.2. Research Execution
  2.2.1. Initiation: Research Process
  2.2.2. Planning: Develop Research Plan
  2.2.3. Execution: Conduct Research
  2.2.4. Verification: Finding & Analysis
  2.2.5. Publication: Research Report
2.3. Research Outcome

3. EXECUTIVE SUMMARY

3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Distribution Channel Outlook
3.5. Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. MARKET OVERVIEW

4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. MARKET INSIGHTS

5.1. Market Dynamics
  5.1.1. Drivers
    5.1.1.1. Increasing demand for specialty drugs to treat complex or serious chronic conditions
    5.1.1.2. Increased reimbursement through the medical benefit, and pharmacy benefit
    5.1.1.3. Specialty pharmacy providers collaborating with pharma/biotech manufacturers, payers, MCOs and patients
    5.1.1.4. Attractive prospects for biopharmaceutical companies from both business and medical innovation perspective
  5.1.2. Restraints
    5.1.2.1. Cost sharing discourages the use leading to adverse health outcomes
    5.1.2.2. Growth in premium costs
  5.1.3. Opportunities
    5.1.3.1. Retailers involvements in specialty market and several chains operate their own specialty pharmacy divisions
    5.1.3.2. Stimulated diagnostic research
    5.1.3.3. Vendors offering compliance programs, reimbursement assistance programs and distribution channels
    5.1.3.4. Growth of enhanced information technologies in the specialty sector
    5.1.3.5. Value-added programs targeting physicians, nurses, patients and caregivers
  5.1.4. Challenges
    5.1.4.1. Less focus on development of low-cost generic equivalents of specialty drugs
5.2. Porters Five Forces Analysis
  5.2.1. Threat of New Entrants
  5.2.2. Threat of Substitutes
  5.2.3. Bargaining Power of Customers
  5.2.4. Bargaining Power of Suppliers
  5.2.5. Industry Rivalry

6. GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY TYPE

6.1. Introduction
6.2. CNS
6.3. Infectious diseases
6.4. Momen’s health
6.5. Oncology
6.6. Respiratory

7. GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY PRODUCT

7.1. Introduction
7.2. Oral Pharmaceuticals
7.3. Parenteral Pharmaceuticals
7.4. Transdermal Pharmaceuticals

8. GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL

8.1. Introduction
8.2. Hospitals & Care Providers
8.3. Online Mode
8.4. Retail Pharmacies
8.5. Specialty Pharmacies

9. AMERICAS SPECIALTY PHARMACEUTICALS MARKET

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET

11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. COMPETITIVE LANDSCAPE

12.1. FPNV Positioning Matrix
  12.1.1. Quadrants
  12.1.2. Business Strategy
  12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
  12.5.1. Merger & Acquisition
  12.5.2. Agreement, Collaboration, & Partnership
  12.5.3. New Product Launch & Enhancement
  12.5.4. Investment & Funding
  12.5.5. Award, Recognition, & Expansion

13. COMPANY USABILITY PROFILES

13.1. Accredo Health Group, Inc.
13.2. Avella Specialty Pharmacy, Inc.
13.3. CIGNA Pharmacy Management
13.4. CVS Health Corporation
13.5. Diplomat Pharmacy, Inc.
13.6. Endo Pharmaceuticals Inc.
13.7. ENESI
13.8. Humana Pharmacy, Inc.
13.9. Hyphens Pharma Pte Ltd.
13.10. Kroger Specialty Pharmacy, Inc.
13.11. McKesson Corporation
13.12. Midatech Pharma PLC
13.13. UnitedHealth Group Incorporated
13.14. US WorldMeds, LLC
13.15. Walgreens Boots Alliance, Inc.

14. APPENDIX

14.1. Discussion Guide
14.2. License & Pricing

LIST OF TABLES

TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. ARGENTINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. BRAZIL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. BRAZIL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CANADA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CANADA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CANADA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. MEXICO SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. MEXICO SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. MEXICO SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. AUSTRALIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. AUSTRALIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. AUSTRALIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. CHINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. CHINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CHINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. INDIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. INDIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDONESIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDONESIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDONESIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. JAPAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. JAPAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. JAPAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. MALAYSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. MALAYSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MALAYSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. PHILIPPINES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. PHILIPPINES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. PHILIPPINES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH KOREA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH KOREA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH KOREA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. THAILAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. THAILAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. THAILAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. FRANCE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. FRANCE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. FRANCE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GERMANY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. GERMANY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. GERMANY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. ITALY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. ITALY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. ITALY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. NETHERLANDS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. NETHERLANDS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. NETHERLANDS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. QATAR SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. QATAR SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. QATAR SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. RUSSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. RUSSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. RUSSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. SAUDI ARABIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SAUDI ARABIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SAUDI ARABIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SPAIN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SPAIN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SPAIN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. UNITED ARAB EMIRATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. UNITED ARAB EMIRATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED ARAB EMIRATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED KINGDOM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED KINGDOM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED KINGDOM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: SCORES
TABLE 107. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 108. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 109. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: RANKING
TABLE 110. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 111. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 112. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 113. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 114. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 115. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: LICENSE & PRICING


LIST OF FIGURES

FIGURE 1. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 6. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 7. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 23. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2025
FIGURE 25. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ORAL PHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PARENTERAL PHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TRANSDERMAL PHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
FIGURE 29. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 31. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONLINE MODE, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY SPECIALTY PHARMACIES, 2020 VS 2025 (USD MILLION)
FIGURE 35. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 36. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. ARGENTINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. BRAZIL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. CANADA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. MEXICO SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. UNITED STATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 44. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 46. AUSTRALIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. CHINA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. INDIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. INDONESIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. JAPAN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. MALAYSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. PHILIPPINES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SOUTH KOREA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. THAILAND SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 58. FRANCE SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. GERMANY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. ITALY SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. NETHERLANDS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. QATAR SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. RUSSIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SAUDI ARABIA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. SOUTH AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. SPAIN SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. UNITED KINGDOM SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 71. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY TYPE


More Publications